Related Experiment Video
Updated: Nov 10, 2025

10:21
Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells
Published on: January 5, 2018
13.4K
Interrogating immune cells and cancer with CRISPR-Cas9
Frank A Buquicchio1, Ansuman T Satpathy2
1Program in Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Trends in Immunology
|April 4, 2021
Summary
CRISPR-Cas9 gene editing advances immunology research and cancer immunotherapy development. This review details CRISPR-Cas9 applications for discovering immune system regulators and designing novel cancer treatments.
Area of Science:
- Immunology
- Genetics
- Cancer Research
Background:
- CRISPR-Cas9 technology revolutionizes genetic pathway studies.
- Recent adaptations target immune cells, boosting functional genomics.
- This accelerates development of cellular immunotherapies for cancer.
Purpose of the Study:
- To review recent CRISPR-Cas9 developments.
- To discuss their application in immune system research.
- To highlight their role in immuno-oncology.
Main Methods:
- Review of recent CRISPR-Cas9 technology advancements.
- Analysis of CRISPR-Cas9 applications in immune cell research.
- Exploration of CRISPR-Cas9-based screens in immunology.
Main Results:
- CRISPR-Cas9 has transformed the study of cellular differentiation and function.
- Adapted CRISPR-Cas9 methods accelerate functional genomics in immunology.
- New avenues for cancer cellular immunotherapy design are enabled.
Conclusions:
- CRISPR-Cas9 is a powerful tool for discovering and manipulating immune system regulators.
- This technology is crucial for advancing immuno-oncology.
- The review serves as a resource for CRISPR-Cas9 based screens in immunology and cancer therapy.
Related Concept Videos
CRISPR/Cas9 Genome Editing
897
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
897
CRISPR
54.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
54.2K
CRISPR and crRNAs
18.1K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.1K
The Antiviral System of Bacteria and Archaea: CRISPR
368
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
368
Homologous Recombination
58.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
58.5K

